Illustrative image by Nixx Photography/Shutterstock.com

When Israeli regenerative medicine company Collplant inked a licensing and commercialization deal with major American biotech firm United Therapeutics Corporation in November to make 3D bioprinted lungs, the news exploded across the Internet. The 3D printed lungs, to be created using the combined technologies of the two companies, are planned for lung transplant surgeries anywhere in the world. If all goes well, three additional organs will follow, in a development that could completely transform the way we approach organ transplant. Collplant is one of many companies founded by Hebrew University nanotech pioneer, Prof. Oded Shoseyov, whom we featured in June.